A Conversation About the FDA's Regulation of Mifepristone
JAMA Clinical Reviews
00:00
Five key regulatory moments since 2011
Alexander outlines five pivotal moments shaping the mifepristone REMS from 2011 through 2021 and pandemic-related changes.
Play episode from 09:13
Transcript


